Log in to save to my catalogue

Recombinant TLR5 Agonist CBLB502 Promotes NK Cell-Mediated Anti-CMV Immunity in Mice

Recombinant TLR5 Agonist CBLB502 Promotes NK Cell-Mediated Anti-CMV Immunity in Mice

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1530613186

Recombinant TLR5 Agonist CBLB502 Promotes NK Cell-Mediated Anti-CMV Immunity in Mice

About this item

Full title

Recombinant TLR5 Agonist CBLB502 Promotes NK Cell-Mediated Anti-CMV Immunity in Mice

Publisher

United States: Public Library of Science

Journal title

PloS one, 2014-05, Vol.9 (5), p.e96165-e96165

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Prior work using allogeneic bone marrow transplantation (allo-BMT) models showed that peritransplant administration of flagellin, a toll-like receptor 5 (TLR5) agonist protected murine allo-BMT recipients from CMV infection while limiting graft-vs-host disease (GvHD). However, the mechanism by which flagellin-TLR5 interaction promotes anti-CMV immu...

Alternative Titles

Full title

Recombinant TLR5 Agonist CBLB502 Promotes NK Cell-Mediated Anti-CMV Immunity in Mice

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1530613186

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1530613186

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0096165

How to access this item